BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38741410)

  • 1. Formulation design and characterization of silymarin liposomes for enhanced antitumor activity.
    Ke Z; Cheng X; Yang H; Niu Y; Cheng X; Ye T; Sun G; Cheng Z; Sun Y
    Pak J Pharm Sci; 2024 Jan; 37(1):139-145. PubMed ID: 38741410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced oral bioavailability of silymarin using liposomes containing a bile salt: preparation by supercritical fluid technology and evaluation in vitro and in vivo.
    Yang G; Zhao Y; Zhang Y; Dang B; Liu Y; Feng N
    Int J Nanomedicine; 2015; 10():6633-44. PubMed ID: 26543366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
    Shaji J; Menon I
    Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved hepatoprotective activity of silymarin via encapsulation in the novel vesicular nanosystem bilosomes.
    Mohsen AM; Asfour MH; Salama AAA
    Drug Dev Ind Pharm; 2017 Dec; 43(12):2043-2054. PubMed ID: 28756693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization on conditions of podophyllotoxin-loaded liposomes using response surface methodology and its activity on PC3 cells.
    Wu Z; Wang T; Song Y; Lu Y; Chen T; Chen P; Hui A; Chen Y; Wang H; Zhang W
    J Liposome Res; 2019 Jun; 29(2):133-141. PubMed ID: 30022692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study.
    Zare-Zardini H; Alemi A; Taheri-Kafrani A; Hosseini SA; Soltaninejad H; Hamidieh AA; Haghi Karamallah M; Farrokhifar M; Farrokhifar M
    Drug Des Devel Ther; 2020; 14():3315-3324. PubMed ID: 32884236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and Evaluation of Rifampicin Liposomes for Buccal Drug Delivery.
    Lankalapalli S; Tenneti VS
    Curr Drug Deliv; 2016; 13(7):1084-1099. PubMed ID: 26687256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascorbic acid derivative-loaded modified aspasomes: formulation,
    Aboul-Einien MH; Kandil SM; Abdou EM; Diab HM; Zaki MSE
    J Liposome Res; 2020 Mar; 30(1):54-67. PubMed ID: 30821553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of hybrid liposomes-encapsulated silymarin regarding physical stability and in vivo performance.
    El-Samaligy MS; Afifi NN; Mahmoud EA
    Int J Pharm; 2006 Aug; 319(1-2):121-9. PubMed ID: 16837151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Long-circulating DOX Liposome: Formulation and Pharmacokinetics Studies.
    Xiao P; Zhao J; Huang Y; Jin R; Tang Z; Wang P; Song X; Zhu H; Yang Z; Yu N
    Pharm Nanotechnol; 2020; 8(5):391-398. PubMed ID: 32787769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and pharmacological evaluation of silibinin liposomes.
    Maheshwari H; Agarwal R; Patil C; Katare OP
    Arzneimittelforschung; 2003; 53(6):420-7. PubMed ID: 12872613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of silymarin-loaded amphiphilic chitosan polymeric micelles on the renal toxicity and anticancer activity of cisplatin.
    Soodvilai S; Tipparos W; Rangsimawong W; Patrojanasophon P; Soodvilai S; Sajomsang W; Opanasopit P
    Pharm Dev Technol; 2019 Oct; 24(8):927-934. PubMed ID: 30526167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability enhancement of voriconazole using liposomal pastilles: Formulation and experimental design investigation.
    Lankalapalli S; Vemuri VD; Tenneti VSVK; Guntaka PR
    J Liposome Res; 2022 Sep; 32(3):293-307. PubMed ID: 34923884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of isoniazid-loaded crude soybean lecithin liposomes.
    Nkanga CI; Krause RW; Noundou XS; Walker RB
    Int J Pharm; 2017 Jun; 526(1-2):466-473. PubMed ID: 28461265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dextrose modified bilosomes for peroral delivery: improved therapeutic potential and stability of silymarin in diethylnitrosamine-induced hepatic carcinoma in rats.
    Parashar P; Rana P; Dwivedi M; Saraf SA
    J Liposome Res; 2019 Sep; 29(3):251-263. PubMed ID: 30501440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterization, and in vivo pharmacodynamic evaluation of parenteral diclofenac submicron lipid emulsions.
    Varshika E; Prabhakar K; Kishan V
    PDA J Pharm Sci Technol; 2009; 63(5):380-9. PubMed ID: 20158044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic Antitumor Efficacy Mediated by Liposomal Co-Delivery of Polymeric Micelles of Vinorelbine and Cisplatin in Non-Small Cell Lung Cancer.
    Wang S; Gou J; Wang Y; Tan X; Zhao L; Jin X; Tang X
    Int J Nanomedicine; 2021; 16():2357-2372. PubMed ID: 33790554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of docetaxel-loaded lecithin-stabilized micellar drug delivery system (L
    Su CY; Liu JJ; Ho YS; Huang YY; Chang VH; Liu DZ; Chen LC; Ho HO; Sheu MT
    Eur J Pharm Biopharm; 2018 Feb; 123():9-19. PubMed ID: 29154834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved in vitro and in vivo hepatoprotective effects of liposomal silymarin in alcohol-induced hepatotoxicity in Wistar rats.
    Kumar N; Rai A; Reddy ND; Shenoy RR; Mudgal J; Bansal P; Mudgal PP; Arumugam K; Udupa N; Sharma N; Rao CM
    Pharmacol Rep; 2019 Aug; 71(4):703-712. PubMed ID: 31207432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating Artificial Intelligence with Quality by Design in the Formulation of Lecithin/Chitosan Nanoparticles of a Poorly Water-Soluble Drug.
    Dawoud MHS; Mannaa IS; Abdel-Daim A; Sweed NM
    AAPS PharmSciTech; 2023 Aug; 24(6):169. PubMed ID: 37552427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.